Evaluation of the Neutrophil-Based Inflammatory Indexes SIRI and NHR in Patients with Extensive-Stage Small Cell Lung Cancer Receiving First-Line Immune Checkpoint Inhibitors Plus Chemotherapy.
The baseline serum SIRI and NHR can serve as promising indicators of prognosis, but not treatment response, in ES-SCLC patients receiving first-line ICIs and chemotherapy.
Authors
- H.H.M. Yu
- Xiaojing Wang (ORCID: https://orcid.org/0000-0002-9636-6511)
- Jing Liu (ORCID: https://orcid.org/0000-0002-3113-4015)
- Yan Yang (ORCID: https://orcid.org/0000-0001-7167-0261)
- Xinyi Han (ORCID: https://orcid.org/0009-0003-0549-8645)
- Yu Shao
Institutions
- Bengbu Medical College (CN)
- First Affiliated Hospital of Bengbu Medical College (CN)
Publication Details
- Journal
- PubMed
- Published
- 2025-05-01
- Primary Topic
- Inflammatory Biomarkers in Disease Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00